Another major derailing event for CHM. Lead therapy is now in the clinic….
only a single dose of CDH17 CART is contemplated for each patient for the trial. If we see early efficacy signals and low toxicity during the dose escalation then LOOKOUT!
- Forums
- ASX - By Stock
- CHM
- Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.3¢

Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.323M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 250992 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 92511310 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 73880206 | 0.003 |
26 | 26746484 | 0.002 |
12 | 52464000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 92511309 | 25 |
0.005 | 32898062 | 21 |
0.006 | 15579018 | 20 |
0.007 | 6904829 | 8 |
0.008 | 7317101 | 5 |
Last trade - 09.40am 28/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online